Author/Creator: Galebach, P. - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Galebach, P.

1. 3087 Characteristics and treatment patterns of ALK+ NSCLC patients who receive second-generation ALK inhibitors: A chart review study. (September 2015)

Authors:: Cadranel, J.; Park, K.; Pless, M.; Bendaly, E.; Patel, D.; Sasane, M.; Swallow, E.; Galebach, P.; Stein, K.; Marinsek, N.; Zhang, J.
Journal:: European journal of cancer
Issue:: Volume 51:(2015)Supplement 3
Page Start:: S627
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. FRI0129 Assessing the Economic Impact of Comprehensive Disease Control on Total Direct Medical Expenditures for Rheumatoid Arthritis. (9th June 2015)

Authors:: Emery, P.; Kavanaugh, A.; Bao, Y.; Betts, K.A.; Macalalad, A.R.; Lin, P.; Galebach, P.; Garg, V.
Journal:: Annals of the rheumatic diseases
Issue:: Volume 74(2015)Supplement 2
Page Start:: 468
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Treatment, overall survival, and costs in patients with ALK-positive non-small-cell lung cancer after crizotinib monotherapy. (3rd August 2015)

Authors:: Guérin, A.; Sasane, M.; Wakelee, H.; Zhang, J.; Culver, K.; Dea, K.; Nitulescu, R.; Galebach, P.; Macalalad, A.R.
Journal:: Current medical research and opinion
Issue:: Volume 31:Number 8(2015:Aug.)
Page Start:: 1587
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗